Journals
Publish with us
Publishing partnerships
About us
Blog
Oxidative Medicine and Cellular Longevity
Journal overview
For authors
For reviewers
For editors
Table of Contents
Special Issues
Oxidative Medicine and Cellular Longevity
/
2021
/
Article
/
Tab 1
/
Research Article
A Novel Ruthenium-Fluvastatin Complex Downregulates SNCG Expression to Modulate Breast Carcinoma Cell Proliferation and Apoptosis via Activating the PI3K/Akt/mTOR/VEGF/MMP9 Pathway
Table 1
Ligand with its binding energy values from docking studies.
Name
Electrostatic energy
Van der waals energy
Cdocker energy
Cdocker_interaction energy
Calculate binding energy
H-bond count
Interacting amino acids
Ruthenium-fluvastatin
-23.168
3.03
-234.9
45.31
-56.3119
2
Thr59,Asn64, Val66, Ser67, Glu68, Val71